期刊文献+

狼疮肾炎患者血清IL-31水平的表达与疾病活动性研究 被引量:1

The research on the expression of serum IL-31 and disease activity in patients with lupus nephritis
下载PDF
导出
摘要 目的探讨狼疮肾炎(lupus nephritis,LN)患者血清白介素(interleukin,IL)-31水平的表达及其与肾脏疾病活动度的关系。方法选取九江市第一人民医院诊断LN患者54例作为观察组,前瞻性研究分析观察组基线及随访期临床数据。另外,选取体检中心28名健康人作为对照组,ELISA法检测各组血清IL-31水平的表达,并采用Spearman相关分析与疾病活动指标的相关性。结果观察组患者根据整体系统性红斑狼疮疾病活动指数(systemic lupus erythematosus disease activity index,SLEDAI)评分是否≥10分,分为活动组(≥10分,38例)及稳定组(<10分,16例),两组血清IL-31表达水平有明显差异[(83.7±16.2)ng/L比(72.5±14.1)ng/L,P=0.019];两组与健康对照组的(30.6±9.8)ng/L比较,差异均具有统计学意义。观察组患者未治疗前血清IL-31水平为(81.2±15.7)ng/L,明显高于免疫抑制剂治疗后的水平(71.4±16.3)ng/L(P=0.001)。Spearman相关分析观察组患者血清IL-31水平与SLEDAI评分(r=0.406,P=0.002)、24 h尿蛋白定量(r=0.529,P<0.001)、LN病理活动指数Austin评分(r=0.469,P=0.011)呈正相关;与细胞因子IL-6(r=0.670,P=0.026)、肿瘤坏死因子-α(tumor necrosis factor-α,TNF-α)(r=0.597,P=0.019)等水平呈一致性表达,与血清补体C3(r=-0.427,P=0.001)呈负相关。结论LN患者血清IL-31水平表达较高,且与疾病活动性呈正相关。 Objective To discuss the expression of serum IL-31 in patients with lupus nephritis(LN)and its correlation with kidney disease activity.Methods The clinical data of 54 patients with LN diagnosed in the First People’s Hospital of Jiujiang during the baseline and follow-up period(experimental group)were analyzed prospectively.Another 28 healthy people(control group)were selected from the physical examination center.The expression of serum IL-31 in each group was detected by ELISA.Its correlation with disease activity index was analyzed by Spearman correlation analysis.Result A total of 54 patients in LN experimental group were divided into active group(38 cases)and stable group(16 cases)according to whether the SLEDAI(SLE disease activity index)score was≥10.There was a significant difference in serum IL-31 expression between the two groups(83.7±16.2 vs.72.5±14.1)ng/L(P=0.019).There was significant difference between the two groups and the healthy control group(30.6±9.8)ng/L.The level of serum IL-31 in the LN group before treatment was significantly higher than that after immunosuppressive therapy(81.2±15.7 vs.71.4±16.3)ng/L(P=0.001).Spearman correlation analysis showed that the serum level of IL-31 in the experimental group was positively correlated with the overall SLEDAI score(r=0.406,P=0.002),24-h urine protein quantity(r=0.529,P<0.001),and LN pathological activity index Austin score(r=0.469,P=0.011).The expression was consistent with the levels of IL-6(r=0.670,P=0.026)and TNF-α(r=0.597,P=0.019),and was negatively correlated with serum complement C3(r=-0.427,P=0.001).Conclusion The level of IL-31 in LN patients is higher than that in healthy people,and it is positively related to disease activity.
作者 张丰萍 于乐 李刚 冯晓然 ZHANG Feng-ping;YU Le;LI Gang;FENG Xiao-ran(Department of Nephrology,the First People's Hospital of Jiujiang,Jiujiang 332000,China)
出处 《临床肾脏病杂志》 2020年第9期727-730,共4页 Journal Of Clinical Nephrology
基金 2018年江西省卫生计生委科技计划项目(No.20187109)。
关键词 狼疮肾炎 活动指数 SLEDAI评分 Lupus nephritis Activity index SLEDAI score
  • 相关文献

参考文献2

二级参考文献26

  • 1弓娟琴,陈志强.红斑狼疮的诊断和治疗[J].中华皮肤科杂志,2005,38(1):61-63. 被引量:23
  • 2汪国生,单曙光,杨国俊,张宏,李向培,钱龙,厉小梅.三种自身抗体联合检测对狼疮疾病活动和狼疮肾炎的价值[J].中华风湿病学杂志,2006,10(3):166-168. 被引量:6
  • 3章海涛,胡伟新.系统性红斑狼疮的发病机制[J].肾脏病与透析肾移植杂志,2006,15(1):66-71. 被引量:16
  • 4胡伟新,刘春蓓,孙海鸥,刘正钊,谢红浪,章海涛,陈惠萍,曾彩虹,刘志红,黎磊石.1352例狼疮性肾炎的临床与免疫学特征[J].肾脏病与透析肾移植杂志,2006,15(5):401-408. 被引量:48
  • 5Glassock RJ. Reclassification of lupus glomerulonephritis: back to the future. J Am Soc Nephrol, 2004, 15: 501-503.
  • 6Pollak VE, Pirani CL, Schwartz FD. The natural history of the reual manifestations of systemic lupus erythematosus. J Lab Clin Med, 1964, 63: 537-550.
  • 7Chan TM, Li FK, Tang CSO, et al. Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. New Engl J Med, 2000, 343: 1156-1162.
  • 8Contreras G, Pardo V, Leclercq B, et al. Sequential therapies for proliferative lupus nephritis. New Engl J Med, 2004,350: 971-980.
  • 9Weening JJ, D′Agati VD, Schwartz MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited.Kidney International, 2004, 65: 521-530.
  • 10Austin HA Ⅲ, Klippel JH, Balow JE, et al. Therapy of lupus nephritis: controlled trial of prednisone and cytotoxic drugs. New Engl J Med, 1986, 314: 614-619.

共引文献36

同被引文献16

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部